About: end-stage liver disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: end-stage liver disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

final stage of a liver disease when the liver failure is irreversible and liver transplantation is needed

Attributes	Values
rdf:type	Item
description	final stage of a liver disease when the liver failure is irreversible and liver transplantation is needed (en)
exact match	wds:Q54974362-85C41AE9-5DCE-4B4B-9D9D-F82AB349CF4D
exact match	http://purl.obolibrary.org/obo/HP_0100626
Experimental Factor Ontology ID	wds:Q54974362-05560D81-1699-4847-A7D6-A654B905DB8B
health specialty	wds:Q54974362-3DF782FD-8762-45A7-8B2E-FF5109005A4A
Experimental Factor Ontology ID	1001311
health specialty	gastroenterology
rdfs:label	end-stage liver disease (en) insuffisance hépatique terminale (fr)
skos:prefLabel	end-stage liver disease (en) insuffisance hépatique terminale (fr)
name	end-stage liver disease (en) insuffisance hépatique terminale (fr)
instance of	wds:Q54974362-36a9a18f-4354-a903-24a9-f8b6521fe0b1
instance of	disease
subclass of	wds:Q54974362-8f411300-4f99-03d0-7b81-745cd93773b6
subclass of	liver failure
Human Phenotype Ontology ID	wds:Q54974362-4D902D22-4929-46C3-BAE1-326AD1E2D680
Human Phenotype Ontology ID	HP:0100626
NCI Thesaurus ID	wds:Q54974362-1B181FC5-52BA-40DD-8AF5-5C2487D8F074
UMLS CUI	wds:Q54974362-1ECC4C33-D095-4C7A-9AA8-B1774B6669AF
MeSH descriptor ID	wds:Q54974362-E39381AD-E681-4CE5-A6AE-1DF151B6A1B8
MeSH tree code	wds:Q54974362-F74B90CF-EBF9-457E-9EA7-8EDDD2ABC5D3
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/D058625
MeSH tree code	http://id.nlm.nih.gov/mesh/C06.552.308.500.177
NCI Thesaurus ID	C84428
UMLS CUI	C2936476
MeSH descriptor ID	D058625
MeSH tree code	C06.552.308.500.177
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q54974362
is main subject of	Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection End-stage liver disease without hemochromatosis associated with elevated hepatic iron index Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores. Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation. Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes. Impact of Model for End-Stage Liver Disease score on transfusion rates in liver transplantation. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation Impact of nutritional status of Egyptian patients with end-stage liver disease on their outcomes after living donor liver transplantation Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors A model to predict survival in patients with end-stage liver disease Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation Nutrition in end-stage liver disease: principles and practice Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. Spontaneous bacterial peritonitis and bacteremia due to Leuconostoc species in a patient with end-stage liver disease: a case report The model for end-stage liver disease (MELD) Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases Oral management of the patient with end-stage liver disease and the liver transplant patient Model for end-stage liver disease (MELD) exception for portopulmonary hypertension Bispectral index monitoring in healthy, cirrhotic, and end-stage liver disease patients undergoing hepatic operation. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Autonomic dysfunction in end-stage liver disease manifested as defecation syncope: impact of orthotopic liver transplantation Beyond the Pediatric end-stage liver disease system: solutions for infants with biliary atresia requiring liver transplant Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients Living donor liver transplantation for end-stage liver disease with severe hepatopulmonary syndrome: report of a case. Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after Outcomes among patients with end-stage liver disease who are coinfected with HIV and hepatitis C virus Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites [Low response rate to a vaccination against hepatitis B in patients with end-stage liver disease] The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose Markers of bacterial translocation in end-stage liver disease Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Spur cell anemia in end-stage liver disease: a zebra! Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis Complications of end-stage liver disease Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database Serum leptin and insulin in paediatric end-stage liver disease and following successful orthotopic liver transplantation Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk Geographic differences in event rates by model for end-stage liver disease score Model for end-stage liver disease (MELD) exception guidelines Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score Model for end-stage liver disease (MELD) and allocation of donor livers Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs Global lessons in graft type and pediatric liver allocation: A path toward improving outcomes and eliminating wait-list mortality Modified pediatric end-stage liver disease scoring system and pediatric liver transplantation in Brazil National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004) Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software